American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, … Read more
American Oncology Network Inc. (AONC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: 0.110x
Based on the latest financial reports, American Oncology Network Inc. (AONC) has a cash flow conversion efficiency ratio of 0.110x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($11.93 Million) by net assets ($108.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
American Oncology Network Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how American Oncology Network Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
American Oncology Network Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of American Oncology Network Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AM Locales Property Socimi
MC:YAML
|
0.112x |
|
Century Therapeutics Inc
NASDAQ:IPSC
|
-0.145x |
|
INTERGRATED DIA.H DL 025
F:8I8
|
N/A |
|
Dongnan Electronics Co. Ltd. A
SHE:301359
|
N/A |
|
Shinsegae Inte
KO:031430
|
-0.046x |
|
Share India Securities Limited
NSE:SHAREINDIA
|
-0.081x |
|
Tah Hsin Industrial Corp
TW:1315
|
0.035x |
|
Kaltura Inc
NASDAQ:KLTR
|
0.523x |
Annual Cash Flow Conversion Efficiency for American Oncology Network Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of American Oncology Network Inc. from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $108.01 Million | $-4.94 Million | -0.046x | +82.14% |
| 2023-12-31 | $70.71 Million | $-18.12 Million | -0.256x | -134.22% |
| 2022-12-31 | $62.02 Million | $-6.78 Million | -0.109x | -1909.83% |
| 2021-12-31 | $226.04 Million | $-1.23 Million | -0.005x | -100.00% |
| 2020-12-31 | $24.17K | $37.24 Million | 1541.215x | -- |